Sebastiaan Engelborghs unpaid staff

Publications Sebastiaan Engelborghs

Real-world brain volumetry in multiple sclerosis : importance of methodological consistency and clinical relevance of gray matter atrophy

Source
Frontiers in neurology - ISSN 1664-2295-16 (2025) p. 1-12
Author(s)
    Joke Temmerman, Ann Vanremoortel, Maria Bjerke, Marie B. D'hooghe, Guy Nagels, Ayla Pauwels, Diana Sima, Dirk Smeets, Jeroen Van Schependom, Mandy Wittens, Sebastiaan Engelborghs, Miguel D'haeseleer

The association of diabetes with Alzheimer's disease biomarkers and vascular burden across European aging and memory clinic cohorts

Source
Alzheimer's & dementia - ISSN 1552-5260-21:10 (2025) p. 1-12
Author(s)
    Veerle Van Gils, Willemijn J. Jansen, Wiesje M. Van Der Flier, Pablo Martinez-lage, Jakub Hort, Inez H.G.B. Ramakers, Olivier Rouaud, Markku Laakso, Sebastiaan Engelborghs, Julius Popp, Alberto Lleo, Anders Wallin, Magda Tsolaki, Charlotte E. Teunissen, Rik Vandenberghe, Yvonne Freund-levi, Lutz Frolich, Henrik Zetterberg, Johannes Streffer, Simon Lovestone, Justine Moonen, Argonde Van Harten, Katerina Veverova, Nienke Legdeur, Anouk Den Braber, Daniel Damian, Anette Hall, Janita Bralten, Giuseppe Fanelli, Barbara Franke, Geert Poelmans, Monica Bullo, Susana Jimenez-murcia, Fernando Fernandez-aranda, Jordi Salas-salvado, Soren Dalsgaard, Pieter Jelle Visser, Stephanie J.B. Vos

Assessing the link between cerebellar volume and cognitive function in Alzheimer's disease : a pilot study

Source
Scientific reports - ISSN 2045-2322-15:1 (2025) p. 1-12
Author(s)
    Deborah Van Rossem, Gert-Jan Allemeersch, Nuno Barros, Joke Temmerman, Marijke Desmet, Ilka Ringoot, Annemie Ribbens, Veronique Michiels, Johan De Mey, Chris Baeken, Sebastiaan Engelborghs, Sara De Witte

Machine learning in Alzheimer's disease genetics

Source
Nature communications - ISSN 2041-1723-16:1 (2025) p. 1-16
Author(s)
    Matthew Bracher-Smith, Federico Melograna, Brittany Ulm, Celine Bellenguez, Benjamin Grenier-Boley, Diane Duroux, Alejo J. Nevado, Peter Holmans, Betty M. Tijms, Marc Hulsman, Itziar de Rojas, Rafael Campos-Martin, Sven van der Lee, Atahualpa Castillo, Fahri Küçükali, Oliver Peters, Anja Schneider, Martin Dichgans, Dan Rujescu, Norbert Scherbaum, Juergen Deckert, Steffi Riedel-Heller, Lucrezia Hausner, Laura Molina-Porcel, Emrah Duzel, Timo Grimmer, Jens Wiltfang, Stefanie Heilmann-Heimbach, Susanne Moebus, Thomas Tegos, Nikolaos Scarmeas, Oriol Dols-Icardo, Fermin Moreno, Jordi Perez-Tur, Maria J. Bullido, Pau Pastor, Raquel Sanchez-Valle, Victoria Alvarez, Merce Boada, Pablo Garcia-Gonzalez, Raquel Puerta, Pablo Mir, Luis M. Real, Gerard Pinol-Ripoll, Jose Maria Garcia-Alberca, Kristel Sleegers, Sebastiaan Engelborghs, Christine Van Broeckhoven, Jasper Van Dongen, Mohammad Arfan Ikram

Comment by European Alzheimer's Disease Consortium (EADC) investigators on the negative recommendation of the CHMP on the marketing authorization of donanemab for early Alzheimer' s disease

Source
Journal of Prevention of Alzheimer's Disease - ISSN 2274-5807-12:8 (2025) p. 1-5
Author(s)
    Frank Jessen, Javier Arbizu, Merce Boada, Mircea Balasa, Karim Bennys, Marina Boban, Katharina Burger, Andrea Chincarini, Annachiara Cagnin, Peter Paul De Deyn, Emrah Duezel, Sebastiaan Engelborghs, Michael Ewers, Lieza G. Exalto, Wiesje M. van der Flier, Juan Fortea, Kristian Steen Frederiksen, Giovanni B. Frisoni, Lutz Froelich, Alejandro J. Garza-Martinez, Timo Grimmer, Bernard Hanseeuw, Jakub Hort, Adrian Ivanoiu, Patrick G. Kehoe, Sean P. Kennelly, Silke Kern, Stefan Kloeppel, Lenka Krajcovicova, Milica G. Kramberger, Bernadette McGuinness, Patrizia Mecocci, Timo Jan Oberstein, Pierre-Jean Ousset, Claire Paquet, Robert Perneczky, Fabrizio Piazza, Domenico Plantone, Innocenzo Rainero, Guillaume Sacco, Eric Salm, Isabel Santana, Nikolaos Scarmeas, Anja Schneider, Jonathan M. Schott, Eino Solje, Elka Stefanova, Elisabeth Stogmann, Melanie Strauss, Bengt Winblad